Financials
Financial year 2025
DR. JORIS CALLENS from Knokke-Heist, company number BE0890684385, closed financial year 2025 with a result of € 146,397 after tax. For that financial year DR. JORIS CALLENS recorded a gross margin of € 232,231 and equity of € 484,960. Compared with financial year 2024, the result moved from € 149,740 to € 146,397. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.
€ 484,960
▲ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 146,397
▼ 2% vs 2024
Profit after tax over the fiscal year.
€ 166,758
▲ 33% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 132,842 paid out
91 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 33
▼ 90% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 28,661
▼ 29% vs 2024
€ 12,384 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 18,236
▲ 17% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 33,127
▲ 3% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 92,245 | € -151,295 | € 265,336 | € 232,231 | ▼ 12% |
| Profit after taxes | € 41,900 | € 126,463 | € 149,740 | € 146,397 | ▼ 2% |
| Equity | € 245,201 | € 321,664 | € 471,404 | € 484,960 | ▲ 3% |
| Total debts | € 206,610 | € 111,562 | € 88,140 | € 80,025 | ▼ 9% |
| Cash | € 171,387 | € 75,834 | € 125,201 | € 166,758 | ▲ 33% |
| Land & buildings | € 323,168 | € 0 | - | - | |
| Retained profit | € 176,601 | € 303,064 | € 452,804 | € 466,360 | ▲ 3% |
| Dividend | € 0 | € 0 | € 0 | € 132,842 | |
| Bank debt | € 187,680 | € 73,964 | € 40,505 | € 28,661 | ▼ 29% |
| Balance sheet total | € 812,387 | € 433,226 | € 559,545 | € 564,985 | ▲ 1% |
Key figures of DR. JORIS CALLENS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DR. JORIS CALLENS?
What happened at DR. JORIS CALLENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 146,397 (▼ 2% vs 2024). Source: NBB ↗
- New establishment in Knokke-Heist. KBO
- New establishment in Blankenberge. KBO
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Knokke-Heist. KBO
In short
From € 41,900 profit in 2022 to € 146,397 profit in 2025.
Paid € 220,870 in corporate taxes since 2022.
Best year ever: 2024, with € 149,740 profit.
Paid out € 132,842 in dividends to the owners in total.
Management
Behind DR. JORIS CALLENS is Joris Callens.
Directors
According to the 2025 annual accounts
Joris Callens
Director
Establishments
Establishment units
Physical locations of this company
Cipressenstraat 26
8300 Knokke-Heist
Kalvekeetdijk 260
8300 Knokke-Heist
Active since 1 January 2020
Dr Fr. Verhaeghestraat 1
8370 Blankenberge
Active since 1 January 2020
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- CALLENS Joris Albert Jeroen(oprichter) 100%
Details
- Company number
- 0890.684.385
- VAT number
- BE 0890.684.385
- Registered office
- Cipressenstraat 26, 8300 Knokke-Heist
- Names & denominations
- DR. JORIS CALLENS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 July 2007
- Peppol
- Active · Active since 16 Jul 2026
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied